Google Ventures-Backed Biotech Metsera Seeks $292 Million in IPO

Metsera Inc. is seeking to raise $292 million in an initial public offering, joining a clutch of health-care firms set to make their debuts as public companies.

The New York-based firm plans to market 17.2 million shares for $15 to $17 per share, according to its filing on Monday with the US Securities and Exchange Commission.

At the top of that range, Metsera would have a market value of $1.8 billion based on the outstanding shares listed in its filing.

Metsera is a clinical-stage biotechnology company developing injectable and oral treatments for obesity and related conditions, the filing shows.

The ...